# DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia

> **NCT04836780** · PHASE3 · UNKNOWN · sponsor: **Hospital Universitario Infanta Leonor** · enrollment: 126 (estimated)

## Conditions studied

- COVID-19
- Acute Respiratory Distress Syndrome
- Pneumonia, Viral

## Interventions

- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT04836780
- **Lead sponsor:** Hospital Universitario Infanta Leonor
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-10
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-03-30
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2023-03-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04836780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04836780, "DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04836780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*